The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transdermal Drug Delivery Formulation Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Ointment
1.2.3 Glue
1.2.4 Cataplasm
1.2.5 Other
1.3 Market by Application
1.3.1 Global Transdermal Drug Delivery Formulation Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transdermal Drug Delivery Formulation Market Perspective (2018-2029)
2.2 Transdermal Drug Delivery Formulation Growth Trends by Region
2.2.1 Global Transdermal Drug Delivery Formulation Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Transdermal Drug Delivery Formulation Historic Market Size by Region (2018-2023)
2.2.3 Transdermal Drug Delivery Formulation Forecasted Market Size by Region (2024-2029)
2.3 Transdermal Drug Delivery Formulation Market Dynamics
2.3.1 Transdermal Drug Delivery Formulation Industry Trends
2.3.2 Transdermal Drug Delivery Formulation Market Drivers
2.3.3 Transdermal Drug Delivery Formulation Market Challenges
2.3.4 Transdermal Drug Delivery Formulation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transdermal Drug Delivery Formulation Players by Revenue
3.1.1 Global Top Transdermal Drug Delivery Formulation Players by Revenue (2018-2023)
3.1.2 Global Transdermal Drug Delivery Formulation Revenue Market Share by Players (2018-2023)
3.2 Global Transdermal Drug Delivery Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transdermal Drug Delivery Formulation Revenue
3.4 Global Transdermal Drug Delivery Formulation Market Concentration Ratio
3.4.1 Global Transdermal Drug Delivery Formulation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery Formulation Revenue in 2022
3.5 Transdermal Drug Delivery Formulation Key Players Head office and Area Served
3.6 Key Players Transdermal Drug Delivery Formulation Product Solution and Service
3.7 Date of Enter into Transdermal Drug Delivery Formulation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transdermal Drug Delivery Formulation Breakdown Data by Type
4.1 Global Transdermal Drug Delivery Formulation Historic Market Size by Type (2018-2023)
4.2 Global Transdermal Drug Delivery Formulation Forecasted Market Size by Type (2024-2029)
5 Transdermal Drug Delivery Formulation Breakdown Data by Application
5.1 Global Transdermal Drug Delivery Formulation Historic Market Size by Application (2018-2023)
5.2 Global Transdermal Drug Delivery Formulation Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Transdermal Drug Delivery Formulation Market Size (2018-2029)
6.2 North America Transdermal Drug Delivery Formulation Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Transdermal Drug Delivery Formulation Market Size by Country (2018-2023)
6.4 North America Transdermal Drug Delivery Formulation Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transdermal Drug Delivery Formulation Market Size (2018-2029)
7.2 Europe Transdermal Drug Delivery Formulation Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Transdermal Drug Delivery Formulation Market Size by Country (2018-2023)
7.4 Europe Transdermal Drug Delivery Formulation Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transdermal Drug Delivery Formulation Market Size (2018-2029)
8.2 Asia-Pacific Transdermal Drug Delivery Formulation Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Transdermal Drug Delivery Formulation Market Size by Region (2018-2023)
8.4 Asia-Pacific Transdermal Drug Delivery Formulation Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transdermal Drug Delivery Formulation Market Size (2018-2029)
9.2 Latin America Transdermal Drug Delivery Formulation Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Transdermal Drug Delivery Formulation Market Size by Country (2018-2023)
9.4 Latin America Transdermal Drug Delivery Formulation Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transdermal Drug Delivery Formulation Market Size (2018-2029)
10.2 Middle East & Africa Transdermal Drug Delivery Formulation Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Transdermal Drug Delivery Formulation Market Size by Country (2018-2023)
10.4 Middle East & Africa Transdermal Drug Delivery Formulation Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Transdermal Drug Delivery Formulation Introduction
11.1.4 Johnson & Johnson Revenue in Transdermal Drug Delivery Formulation Business (2018-2023)
11.1.5 Johnson & Johnson Recent Development
11.2 Mylan
11.2.1 Mylan Company Detail
11.2.2 Mylan Business Overview
11.2.3 Mylan Transdermal Drug Delivery Formulation Introduction
11.2.4 Mylan Revenue in Transdermal Drug Delivery Formulation Business (2018-2023)
11.2.5 Mylan Recent Development
11.3 Echo Therapeutics
11.3.1 Echo Therapeutics Company Detail
11.3.2 Echo Therapeutics Business Overview
11.3.3 Echo Therapeutics Transdermal Drug Delivery Formulation Introduction
11.3.4 Echo Therapeutics Revenue in Transdermal Drug Delivery Formulation Business (2018-2023)
11.3.5 Echo Therapeutics Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Transdermal Drug Delivery Formulation Introduction
11.4.4 Novartis Revenue in Transdermal Drug Delivery Formulation Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 GSK
11.5.1 GSK Company Detail
11.5.2 GSK Business Overview
11.5.3 GSK Transdermal Drug Delivery Formulation Introduction
11.5.4 GSK Revenue in Transdermal Drug Delivery Formulation Business (2018-2023)
11.5.5 GSK Recent Development
11.6 Hunan Jiudian
11.6.1 Hunan Jiudian Company Detail
11.6.2 Hunan Jiudian Business Overview
11.6.3 Hunan Jiudian Transdermal Drug Delivery Formulation Introduction
11.6.4 Hunan Jiudian Revenue in Transdermal Drug Delivery Formulation Business (2018-2023)
11.6.5 Hunan Jiudian Recent Development
11.7 Tide Pharmaceutical
11.7.1 Tide Pharmaceutical Company Detail
11.7.2 Tide Pharmaceutical Business Overview
11.7.3 Tide Pharmaceutical Transdermal Drug Delivery Formulation Introduction
11.7.4 Tide Pharmaceutical Revenue in Transdermal Drug Delivery Formulation Business (2018-2023)
11.7.5 Tide Pharmaceutical Recent Development
11.8 Luye Pharma
11.8.1 Luye Pharma Company Detail
11.8.2 Luye Pharma Business Overview
11.8.3 Luye Pharma Transdermal Drug Delivery Formulation Introduction
11.8.4 Luye Pharma Revenue in Transdermal Drug Delivery Formulation Business (2018-2023)
11.8.5 Luye Pharma Recent Development
11.9 GDB
11.9.1 GDB Company Detail
11.9.2 GDB Business Overview
11.9.3 GDB Transdermal Drug Delivery Formulation Introduction
11.9.4 GDB Revenue in Transdermal Drug Delivery Formulation Business (2018-2023)
11.9.5 GDB Recent Development
11.10 Anssure Pharma
11.10.1 Anssure Pharma Company Detail
11.10.2 Anssure Pharma Business Overview
11.10.3 Anssure Pharma Transdermal Drug Delivery Formulation Introduction
11.10.4 Anssure Pharma Revenue in Transdermal Drug Delivery Formulation Business (2018-2023)
11.10.5 Anssure Pharma Recent Development
11.11 Novastage
11.11.1 Novastage Company Detail
11.11.2 Novastage Business Overview
11.11.3 Novastage Transdermal Drug Delivery Formulation Introduction
11.11.4 Novastage Revenue in Transdermal Drug Delivery Formulation Business (2018-2023)
11.11.5 Novastage Recent Development
11.12 LIANSN
11.12.1 LIANSN Company Detail
11.12.2 LIANSN Business Overview
11.12.3 LIANSN Transdermal Drug Delivery Formulation Introduction
11.12.4 LIANSN Revenue in Transdermal Drug Delivery Formulation Business (2018-2023)
11.12.5 LIANSN Recent Development
11.13 KBD
11.13.1 KBD Company Detail
11.13.2 KBD Business Overview
11.13.3 KBD Transdermal Drug Delivery Formulation Introduction
11.13.4 KBD Revenue in Transdermal Drug Delivery Formulation Business (2018-2023)
11.13.5 KBD Recent Development
11.14 CosMED Pharmaceutical
11.14.1 CosMED Pharmaceutical Company Detail
11.14.2 CosMED Pharmaceutical Business Overview
11.14.3 CosMED Pharmaceutical Transdermal Drug Delivery Formulation Introduction
11.14.4 CosMED Pharmaceutical Revenue in Transdermal Drug Delivery Formulation Business (2018-2023)
11.14.5 CosMED Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details